Tumor cytotoxicity and immunogenicity of a novel V-jet neon plasma source compared to the kINPen.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
08 01 2021
08 01 2021
Historique:
received:
23
10
2020
accepted:
22
12
2020
entrez:
9
1
2021
pubmed:
10
1
2021
medline:
8
9
2021
Statut:
epublish
Résumé
Recent research indicated the potential of cold physical plasma in cancer therapy. The plethora of plasma-derived reactive oxygen and nitrogen species (ROS/RNS) mediate diverse antitumor effects after eliciting oxidative stress in cancer cells. We aimed at exploiting this principle using a newly designed dual-jet neon plasma source (
Identifiants
pubmed: 33420228
doi: 10.1038/s41598-020-80512-w
pii: 10.1038/s41598-020-80512-w
pmc: PMC7794240
doi:
Substances chimiques
Plasma Gases
0
Reactive Nitrogen Species
0
Reactive Oxygen Species
0
Neon
4VB4Y46AHD
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
136Références
Mutat Res Genet Toxicol Environ Mutagen. 2016 Mar;798-799:48-54
pubmed: 26994493
Cancers (Basel). 2020 Nov 30;12(12):
pubmed: 33265951
Sci Rep. 2019 Mar 11;9(1):4112
pubmed: 30858416
Free Radic Biol Med. 2020 Dec;161:32-49
pubmed: 33011275
Lasers Surg Med. 2018 Jul;50(5):420-426
pubmed: 29399863
Cancer Res. 2005 Sep 15;65(18):8455-60
pubmed: 16166325
Environ Mol Mutagen. 2018 May;59(4):268-277
pubmed: 29417643
Sci Rep. 2017 Jun 5;7(1):2791
pubmed: 28584285
Cancers (Basel). 2019 Aug 23;11(9):
pubmed: 31450811
Biomed Tech (Berl). 2018 Oct 25;63(5):603-608
pubmed: 29727297
PLoS One. 2011;6(11):e28154
pubmed: 22140530
FEBS Lett. 2005 Mar 28;579(9):1951-60
pubmed: 15792802
Nat Med. 2007 Jan;13(1):54-61
pubmed: 17187072
J Immunother Cancer. 2020 Mar;8(1):
pubmed: 32209603
Antioxidants (Basel). 2018 Oct 27;7(11):
pubmed: 30373228
Oncol Lett. 2017 Nov;14(5):6066-6070
pubmed: 29113247
Cancer Immunol Immunother. 2012 Feb;61(2):215-221
pubmed: 22193987
Oncoimmunology. 2014 Dec 13;3(9):e955691
pubmed: 25941621
Nat Rev Immunol. 2001 Nov;1(2):135-45
pubmed: 11905821
In Vivo. 2019 Jul-Aug;33(4):1011-1026
pubmed: 31280189
Redox Biol. 2020 Feb;30:101423
pubmed: 31931281
Cancer Gene Ther. 2020 May 27;:
pubmed: 32457487
Sci Rep. 2018 Aug 24;8(1):12734
pubmed: 30143716
Cancers (Basel). 2020 Sep 09;12(9):
pubmed: 32917026
Anticancer Res. 2019 Jun;39(6):2871-2882
pubmed: 31177125
EMBO J. 2012 Mar 7;31(5):1062-79
pubmed: 22252128
Nat Rev Drug Discov. 2009 Jul;8(7):579-91
pubmed: 19478820
Skin Pharmacol Physiol. 2014;27(1):25-35
pubmed: 23921169
Semin Cancer Biol. 2020 Oct;65:13-27
pubmed: 31362073
Immunol Lett. 2018 Jan;193:25-34
pubmed: 29175313
Oxid Med Cell Longev. 2019 Sep 19;2019:8535163
pubmed: 31641425
Oncol Rep. 2016 Oct;36(4):2268-74
pubmed: 27573888
Biomed Tech (Berl). 2018 Oct 25;63(5):519-527
pubmed: 29522415
Int J Mol Sci. 2020 Feb 18;21(4):
pubmed: 32085661
Annu Rev Immunol. 2013;31:51-72
pubmed: 23157435
Photochem Photobiol Sci. 2011 May;10(5):670-80
pubmed: 21258717
Diagnostics (Basel). 2020 Apr 11;10(4):
pubmed: 32290487
J Craniomaxillofac Surg. 2016 Sep;44(9):1445-52
pubmed: 27499516
Immunity. 2001 Mar;14(3):303-13
pubmed: 11290339
Oncoimmunology. 2018 Jul 26;7(9):e1484978
pubmed: 30228954
Oxid Med Cell Longev. 2017;2017:4271065
pubmed: 28947928
Antioxidants (Basel). 2020 Apr 16;9(4):
pubmed: 32316245
Oxid Med Cell Longev. 2019 Oct 8;2019:9062098
pubmed: 31687089
Nat Rev Cancer. 2012 Dec;12(12):860-75
pubmed: 23151605
Immunol Rev. 2007 Dec;220:22-34
pubmed: 17979837
Cancers (Basel). 2020 Jan 02;12(1):
pubmed: 31906595
Anticancer Res. 2018 Oct;38(10):5655-5663
pubmed: 30275184
Biochemistry. 1998 Apr 21;37(16):5633-42
pubmed: 9548949
Toxicol In Vitro. 1999 Apr;13(2):375-84
pubmed: 20654494
PLoS One. 2009 Jul 27;4(7):e6377
pubmed: 19633716
Sci Rep. 2015 Feb 26;5:8587
pubmed: 25715710
Cell Physiol Biochem. 2019;52(1):119-140
pubmed: 30790509
Cancers (Basel). 2020 Jul 21;12(7):
pubmed: 32708225
Nat Rev Drug Discov. 2019 Mar;18(3):197-218
pubmed: 30610226
Food Chem Toxicol. 1985 Feb;23(2):287-91
pubmed: 4040077
Front Oncol. 2019 Aug 27;9:811
pubmed: 31508370
J Vis Exp. 2017 Nov 17;(129):
pubmed: 29286412
FEBS Lett. 2007 Jul 31;581(19):3689-94
pubmed: 17499247
Int J Cancer. 2014 Apr 1;134(7):1517-28
pubmed: 23754175
Lett Appl Microbiol. 2003;37(1):31-4
pubmed: 12803552
Science. 1995 Oct 13;270(5234):296-9
pubmed: 7569979
Adv Sci (Weinh). 2020 Mar 30;7(10):1903438
pubmed: 32440479
Sci Rep. 2019 Jan 24;9(1):634
pubmed: 30679720
J Biol Chem. 1997 Jan 3;272(1):217-21
pubmed: 8995250
Biochim Biophys Acta. 2010 Jan;1805(1):53-71
pubmed: 19720113
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Cancer. 2014 Sep 1;135(5):1165-77
pubmed: 24500981
Biointerphases. 2015 Jun 06;10(2):029518
pubmed: 25947392
Immunity. 2019 May 21;50(5):1317-1334.e10
pubmed: 30979687
Biol Chem. 2018 Dec 19;400(1):111-122
pubmed: 29908123
Photochem Photobiol. 2020 May;96(3):550-559
pubmed: 32128821
Adv Sci (Weinh). 2019 Jan 28;6(6):1802062
pubmed: 30937272